All stock lists
Greenwich LifeSciences, Inc. (NASDAQ:GLSI)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$14.94-$0.34 (-2.23%)
Market cap
$219M
Insider Score
Health Score
Analyst consensus
Listed since
Sep 25, 2020
Website
Insider Score
––Not scored
GLSI Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
GLSI Stock Insider Trading Activity
GLSI stock’s insider trading shows 5 purchases for an estimated $97.00K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Filters
| Form 4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | Buy | 700 | $13.10 | $9.17K | New | 5,611,402 | Jul 29, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 1,500 | $13.59 | $20.39K | New | 5,610,702 | Jul 28, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 1,500 | $13.62 | $20.43K | New | 5,609,202 | Jul 27, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 1,100 | $12.88 | $14.17K | New | 5,607,702 | Jul 24, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 2,500 | $13.14 | $32.85K | New | 5,606,602 | Jul 23, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 1,800 | $29.83 | $53.69K | New | 5,604,102 | Jan 13, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 2,900 | $27.54 | $79.87K | New | 5,602,302 | Jan 12, 2026 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 4,300 | $21.36 | $91.85K | New | 5,599,402 | Dec 31, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 2,900 | $21.73 | $63.02K | New | 5,595,102 | Dec 30, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 4,100 | $12.62 | $51.74K | New | 5,592,202 | Dec 18, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 4,600 | $8.37 | $38.50K | New | 5,588,102 | Nov 25, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 10,600 | $8.43 | $89.36K | New | 5,583,502 | Nov 7, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 2,300 | $9.26 | $21.30K | New | 5,572,902 | Oct 31, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 3,600 | $9.88 | $35.57K | New | 5,570,602 | Apr 25, 2025 | — | Form 4 |
| Patel Snehal CEO and CFO | Buy | 5,400 | $8.98 | $48.49K | New | 5,567,002 | Apr 17, 2025 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.